# Sources — George H. W. Bush

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 3, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. The White House (archived site). “George H. W. Bush.” Supports his birth in Milton, Massachusetts, on June 12, 1924, and his death on November 30, 2018, at 94. https://bidenwhitehouse.archives.gov/about-the-white-house/presidents/george-h-w-bush/
2. Public Papers of the Presidents of the United States: George H. W. Bush (1991, Book I), p. 473. Statement by the press secretary on the President’s health, May 4, 1991. Supports the onset of atrial fibrillation while running at Camp David, presenting as unusual fatigue; admission to Bethesda Naval Hospital; an electrocardiogram with no abnormality except the irregular rhythm; a cardiac ultrasound with no structural abnormality and normal function; treatment with digoxin; and the editorial note that he was diagnosed with Graves’ disease later in the week. https://www.govinfo.gov/content/pkg/PPP-1991-book1/html/PPP-1991-book1-doc-pg473.htm
3. Public Papers (1991, Book I), pp. 473-474. Statement of May 5, 1991 (morning). Supports continuing atrial fibrillation with no sign of heart damage or heart attack, and procainamide added to digoxin. https://www.govinfo.gov/content/pkg/PPP-1991-book1/html/PPP-1991-book1-doc-pg473-2.htm
4. Public Papers (1991, Book I), pp. 474-475. Statement of May 5, 1991 (evening). Supports that the rhythm had not yet returned to normal and that electrical cardioversion would be considered the next morning. https://www.govinfo.gov/content/pkg/PPP-1991-book1/html/PPP-1991-book1-doc-pg474.htm
5. Public Papers (1991, Book I), p. 475. Statement of May 6, 1991 (morning). Supports the return of normal rhythm late on May 5, recurrence early on May 6, the decision that cardioversion was unnecessary, and discharge. https://www.govinfo.gov/content/pkg/PPP-1991-book1/html/PPP-1991-book1-doc-pg475.htm
6. Public Papers (1991, Book I), pp. 478-479. Statement of May 6, 1991 (evening). Supports normal sinus rhythm through the day after discharge, on digoxin and procainamide. https://www.govinfo.gov/content/pkg/PPP-1991-book1/html/PPP-1991-book1-doc-pg478-2.htm
7. Public Papers (1992, Book I), p. 506. Statements on the President’s physical examination, March 26, 1992. Supports thyroid function “completely normal, on Synthroid .15 milligrams a day,” a normal electrocardiogram with no evidence of heart disease, mild degenerative osteoarthritis on hip and neck x-rays, and stable raised pressure in the left eye without signs of glaucoma. https://www.govinfo.gov/content/pkg/PPP-1992-book1/html/PPP-1992-book1-doc-pg506-2.htm
8. Schwartz AB. “Medical Mystery: A president’s love of exercise reveals an issue.” *The Philadelphia Inquirer*, July 17, 2016 (a physician’s account). Supports a ventricular rate of 150 on arrival, the overactive thyroid as the explanation, treatment with an oral dose of radioactive iodine, a thyroid hormone level that became too low within a few months, and synthetic thyroid hormone for life. https://www.inquirer.com/philly/blogs/healthcare/Medical-Mystery-A-presidents-love-of-exercise-reveals-an-issue.html
9. Newsweek. “Bush Health Mystery.” Supports that he regained eight of the 13 pounds he lost after radioactive iodine was used to control his overactive thyroid. The article date was not shown on the fetched page. https://www.newsweek.com/bush-health-mystery-204148
10. HISTMED Master Roster v3. Internal project source. Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), atrial fibrillation monograph. Every visit: heart rate and rhythm, blood pressure, weight, symptoms, physical activity, alcohol, and tobacco. ECG when rhythm assessment is indicated; echocardiogram at diagnosis; CHA2DS2-VASc and HAS-BLED yearly and with clinical change (anticoagulate at 2 or more in men; shared decision at 1); creatinine at baseline and at least yearly and hemoglobin yearly on a DOAC; sleep apnea screen at diagnosis and yearly; ambulatory monitoring as indicated. https://patrickrutledge.github.io/topthirty/
2. CMID, hypothyroidism monograph. TSH four to eight weeks after each dose change, at six months once stable, then yearly; target 0.4 to 4.0 mIU/L; free T4 during titration; weight, heart rate, blood pressure, and symptoms of under- and over-replacement at each titration visit. https://patrickrutledge.github.io/topthirty/
3. Joglar JA et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation. *Circulation* 2024;149(1):e1-e156. Rate control, risk scoring, anticoagulation at an annual stroke risk of 1 to 2 percent as a shared decision, and management of atrial fibrillation with a reversible trigger. https://pubmed.ncbi.nlm.nih.gov/38033089/
4. Ross DS et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. *Thyroid* 2016;26(10):1343-1421. Diagnosis by TSH receptor antibody, beta-blockade, methimazole pretreatment before radioactive iodine in older patients with cardiac complications, baseline blood count and liver tests, orbitopathy assessment and steroid cover, the choice among radioactive iodine, antithyroid drugs, and surgery, and follow-up of free T4 and total T3 after treatment. https://pubmed.ncbi.nlm.nih.gov/27521067/
5. Jonklaas J et al. Guidelines for the Treatment of Hypothyroidism (American Thyroid Association). *Thyroid* 2014;24(12):1670-1751. Levothyroxine dosing, a lower starting dose in older patients and those with heart disease, and administration on an empty stomach. https://pubmed.ncbi.nlm.nih.gov/25266247/
6. Centers for Medicare & Medicaid Services. Medicare Wellness Visits (Medicare Learning Network). https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/preventive-services/medicare-wellness-visits.html
7. Medicare Preventive Services reference (Aether Forge, 2026). The annual wellness visit template and screening cascade. https://patrickrutledge.github.io/preventative_services/
8. U.S. Preventive Services Task Force: A and B recommendations; colorectal cancer (2021), prostate cancer (2018), abdominal aortic aneurysm (2019), statin use (2022), prediabetes and diabetes (2021), hepatitis C (2020), depression (2023), and falls prevention (2024). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
9. Centers for Disease Control and Prevention. Adult Immunization Schedule by Age. https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html

## Editorial resolutions

- **Recent-death rule.** He died in 2018. The case uses only what the White House and his physicians made public, as published in the Public Papers of the Presidents (the May 1991 statements and the March 1992 physical examination), a physician’s newspaper account, a news report, and the White House biography. No medical records, family accounts, or speculation about undisclosed conditions are used. The scores, laboratory values, doses, rhythm monitoring, anticoagulation, and preventive care are synthetic. The record is kept clinical: his office, work, and public life are not described beyond a generic synthetic occupation, and no political content is included. The recent-death review rule applies.
- **Relatives.** The White House statements of the time also discuss his spouse’s Graves’ disease and a review of possible shared environmental causes. Under the rule against attributing health facts to relatives, this is not used, no family history is recorded, and the spouse is unnamed and gives no history.
- **Physicians named in the sources.** The statements name the White House and hospital physicians. The claims say only “the White House said” and do not attribute decisions to named people.
- **Index age.** The modern episode presents him at 66, four days after the documented onset of atrial fibrillation and in the week Graves’ disease was diagnosed. The synthetic date of birth is June 12, 1959 (shift 35 years). The index visit on May 8, 2026 maps to May 8, 1991; the chronic-care visits on May 20, July 17, and September 11, 2026 map to the same days of 1991; and the annual wellness visit on October 16, 2026 maps to October 16, 1991, when he was 67. The modern hospital stay (May 4 to 6) mirrors the documented one, and the intake ECG in sinus rhythm agrees with the documented return to sinus rhythm. Past medical history includes only the documented episode of atrial fibrillation; the Graves’ diagnosis is made at the index visit.
- **Treatment that differs from the historical record.** The documented treatment of the arrhythmia was digoxin and procainamide. The modern episode uses current care instead: a beta-blocker for rate control, no antiarrhythmic, and a shared anticoagulation decision; the case does not claim he received metoprolol or apixaban. The historical treatment of Graves’ disease was radioactive iodine followed by lifelong thyroid hormone, which the case follows; methimazole pretreatment, the 15 mCi dose, the treatment date (May 29), and the levothyroxine doses (75 then 100 mcg) are synthetic. The exact date of his radioactive iodine treatment was not verified and is not asserted. The documented dose of 0.15 mg a day in March 1992 is later than the episode; the synthetic titration ends at 100 mcg with a TSH in range, which does not contradict it.
- **Synthetic clinical picture.** The fatigue at onset, the fast rate on arrival, the normal heart on ultrasound, the weight loss, and the later hypothyroidism are documented. Other symptoms (heat intolerance, a fine tremor, early hypothyroid symptoms), the diffuse goiter on examination, and all laboratory values are synthetic and were kept to what Graves’ disease and its treatment typically produce. No eye disease is recorded. His height (188 cm) and weights are synthetic. The tobacco and alcohol history (never tobacco; alcohol rarely) is synthetic; no fetched source covers it. CHA2DS2-VASc, HAS-BLED, STOP-BANG, the orbitopathy clinical activity score, and the Timed Up and Go have no verified LOINC code on the terminology server and are recorded as narrative.
- **Annual wellness visit.** A subsequent Medicare annual wellness visit (age 67, so `annual_wellness_subsequent`) was added on October 16, 2026 (true frame October 16, 1991), five weeks after the four-month review. He has been eligible for Medicare since 65, and the visit records an initial annual wellness visit with his previous clinician the year before, so the subsequent visit type applies. No sick visit was added: under the recent-death rule the case adds no synthetic illness episode. Judgment calls: (1) the TSH drawn at the wellness visit (2.6 mIU/L, five weeks after the dose increase) serves as the planned recheck; (2) colorectal screening is recorded as up to date without a result or interval, so that nothing reads as a claim about his real colonoscopy history; (3) he declines PSA testing after shared decision-making, a synthetic choice; (4) the eye examination is due, with Graves’ disease as an added reason; the documented raised eye pressure is later than the episode and is not used; (5) advance care planning names an unnamed agent and records only general priorities, with no treatment preference.
- **Focused visits.** The three chronic-care follow-ups (twelve days after intake, seven weeks after radioactive iodine, and four months after intake) are documented as focused visits on the CMID atrial fibrillation and hypothyroidism monographs, with the 2023 ACC/AHA/ACCP/HRS guideline and the ATA 2016 hyperthyroidism guideline for the thyrotoxic phase, and each lists every item those protocols call for at that point, with its interval and status. Protocol deviation recorded instead of an invented result: the sleep apnea screen due at the diagnosis of atrial fibrillation was missed at intake and at the twelve-day visit and was completed (negative) at the seven-week visit, with no harm and a corrective action. Apixaban was stopped at four months by shared decision after a 14-day ECG patch showed sinus rhythm throughout once he was no longer thyrotoxic (CHA2DS2-VASc 1, trigger treated); this is a judgment call for clinical review.
- **Consultation.** The endocrinology referral and the consultation by Anjali Kapoor, MD (a fictional consultant), on the day of the twelve-day visit, are **S**. The consultant answers the five referral questions with what the record shows happened afterwards: Graves’ disease confirmed without an uptake scan; radioactive iodine chosen over long-term methimazole or surgery and given nine days later; methimazole stopped three days before and not restarted; no orbitopathy and no steroid cover; hypothyroidism found at seven weeks and treated with levothyroxine started at 75 mcg and raised to 100 mcg; and the anticoagulation decision deferred until sinus rhythm was confirmed on ambulatory monitoring.
- **Not used.** His later health history (including the osteoarthritis and eye pressure reported in 1992, and illnesses in old age), the statements about his spouse, and his public office are not used in the episode. The 1992 physical examination is recorded as a claim only.
